Similar articles

• Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.

  Walker WR, Beveridge SJ, Whitehouse MW. Walker WR, et al. Agents Actions Suppl. 1981;8:359-67. Agents Actions Suppl. 1981. PMID: 7008557 Clinical Trial.
• An investigation of the therapeutic value of the 'copper bracelet'-dermal assimilation of copper in arthritic/rheumatoid conditions.

  Walker WR, Keats DM. Walker WR, et al. Agents Actions. 1976 Jul;6(4):454-9. Agents Actions. 1976. PMID: 961545 Clinical Trial.
• Copper complexes and experimental-induced inflammation and arthritis.

  Lewis EJ, West GB. Lewis EJ, et al. Agents Actions Suppl. 1981;8:339-58. Agents Actions Suppl. 1981. PMID: 6781236 No abstract available.
• Physiology and pharmacology of copper.

  Osterberg R. Osterberg R. Pharmacol Ther. 1980;9(1):121-46. doi: 10.1016/0163-7258(80)90019-4. Pharmacol Ther. 1980. PMID: 6994138 Review. No abstract available.
• Development of copper complexes for potential therapeutic use.

  Sorenson JR. Sorenson JR. Agents Actions Suppl. 1981;8:305-25. Agents Actions Suppl. 1981. PMID: 7008556 Review. No abstract available.